Evidence map›Paper›PMID 42789941›Full record

ReviewJournal of food and drug analysis2026

Plant by-products as a valuble source of natural antiglycemic compounds: Economic aspects and alternative raw material sources.

Tatjana Đorđević, Jelena Vujetić, Isidora Dickov, Diandra Pintać Šarac

Abstract readReview
In one paragraph

Review in Journal of food and drug analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tatjana ĐorđevićFaculty of Technology, University of Novi Sad, Bulevar Cara Lazara 1, 21000, Novi Sad, Serbia.
Jelena VujetićInstitute of Food Technology, University of Novi Sad, Bulevar Cara Lazara 1, 21000, Novi Sad, Serbia.
Isidora DickovFaculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000, Novi Sad, Serbia.
Diandra Pintać ŠaracFaculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000, Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant by-products, often considered as waste in various agricultural and food processing industries, have emerged as a valuable source of natural antidiabetic or antihyperglycemic compounds. These compounds, derived from plant materials that would otherwise be discarded, have the potential to mitigate the global burden of diabetes and offer sustainable solutions for glycemic control. Prominent groups of natural antidiabetic compounds found in plant by-products are polyphenols, as well as bioactive proteins and peptides. In addition, agro-industrial residues such as wheat bran, oat husks, and fruit peels are excellent sources of carbohydrates that can be incorporated into functional foods to help manage diabetes. In addition to their antidiabetic potential, plant by-products contribute to sustainability and waste reduction by turning materials that would otherwise be discarded into valuable resources. Furthermore, the utilization of natural antidiabetic compounds from waste materials promises to improve diabetes management and promote a more sustainable food industry. The paper will address the valorization of agro-industrial by-products as natural sources of antiglycemic compounds, including an economic analysis and exploration of different raw material sources. It will present both the advantages and the key challenges associated with the biological activity, metabolism, bioavailability, and toxicological profiles of these compounds, as well as their economic and environmental implications. Furthermore, the review will highlight the prospects for automating this process through the application of artificial intelligence (AI), which may facilitate greater standardization and efficiency in future development.

Indexed as

Diabetes MellitusHypoglycemic AgentsPlant ExtractsPlantsWaste ProductsAnimalsHumansHypoglycemic AgentsPlant ExtractsWaste Products

Identifiers

PMID42789941
PMCPMC13592847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.